The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
KPG-121, a novel cereblon modulator, in patients with metastatic castration resistant prostate cancer: Results of a phase I multiple ascending dose study.
 
Michael Edward Devitt
Consulting or Advisory Role - Astellas Pharma; Seagen
Research Funding - Arvinas (Inst); Kangpu Biopharmaceuticals (Inst); Propella Therapeutics (Inst); Propella Therapeutics (Inst); Seagen (Inst); Syneos Health (Inst); Veru (Inst)
 
Richard Michael Zuniga
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Mirati Therapeutics
 
Alfredo Torres
No Relationships to Disclose
 
H. Keshava Prasad
No Relationships to Disclose
 
Baisong Liao
Stock and Other Ownership Interests - Kangpu Biopharmaceuticals
 
Yao Wang
Stock and Other Ownership Interests - Abbvie; Amgen; Kangpu Biopharmaceuticals